Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

NCT00513188 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: denileukin diftitox
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: doxorubicin hydrochloride
DRUG: leucovorin calcium
DRUG: methotrexate
DRUG: prednisone
DRUG: vincristine sulfate
GENETIC: protein expression analysis
OTHER: flow cytometry
OTHER: laboratory biomarker analysis

Sponsor

University of Miami